Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine for sedation during awake fiberoptic intubation in morbidly obese patients
ChiCTR2300075948Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in difficult airway (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Airway obstruction score. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
difficult airway
Beyond the preview
Go deeper on ChiCTR2300075948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075948.